STK17A Antikörper (AA 115-313)
Kurzübersicht für STK17A Antikörper (AA 115-313) (ABIN1821284)
Target
Alle STK17A Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 115-313
-
Spezifität
- Human DRAK1. No cross-reactivity with recombinant human DRAK2, DAPK1, DAPK2, or DAPK3.
-
Aufreinigung
- Affinity purified
-
Immunogen
-
Recombinant corresponding to aa115-313 from human DRAK1 expressed in E. coli.
Type of Immunogen: Recombinant protein -
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Approved: WB (1 μg/mL)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Sterile PBS to 0.5 mg/mL.
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS, trehalose
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Lyophilized powder may be stored at -20°C. Stable for 1 year at -20°C. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Reconstituted product is stable for 1 year at -20°C.
-
-
- STK17A (serine/threonine Kinase 17a (STK17A))
-
Andere Bezeichnung
- DRAK1 / STK17A
-
Hintergrund
-
Name/Gene ID: STK17A
Subfamily: DAPK
Family: Protein Kinase
Synonyms: STK17A, DRAK1, Serine/threonine kinase 17a -
Gen-ID
- 9263
-
UniProt
- Q9UEE5
Target
-